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Abstract
Background: A rich microbial environment in infancy protects against asthma [1,2] and infections precipitate asthma
exacerbations [3]. We compared the airway microbiota at three levels in adult patients with asthma, the related condition of
COPD, and controls. We also studied bronchial lavage from asthmatic children and controls.
Principal Findings: We identified 5,054 16S rRNA bacterial sequences from 43 subjects, detecting .70% of species present.
The bronchial tree was not sterile, and contained a mean of 2,000 bacterial genomes per cm
2 surface sampled. Pathogenic
Proteobacteria, particularly Haemophilus spp., were much more frequent in bronchi of adult asthmatics or patients with
COPD than controls. We found similar highly significant increases in Proteobacteria in asthmatic children. Conversely,
Bacteroidetes, particularly Prevotella spp., were more frequent in controls than adult or child asthmatics or COPD patients.
Significance: The results show the bronchial tree to contain a characteristic microbiota, and suggest that this microbiota is
disturbed in asthmatic airways.
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Introduction
Asthma is a heterogeneous syndrome of intermittent wheeze and
airway inflammation that affects 300 million individuals worldwide.
Although its causes are unknown, many studies suggest a role for
microbiota in its aetiology [4]. Viral infections are important inducers
of seasonal exacerbations of asthma [5], but there is circumstantial
evidence that bacterial infections may also play a role. Asymptomatic
neonates whose throats are colonized with Streptococcus pneumoniae,
Haemophilus influenzae,o rMoraxella catarrhalis are at increased risk for
recurrent wheeze and asthma early in life [6]. These same bacteria
have consistently been associated with exacerbations of both asthma
[7] and chronic obstructive pulmonary disease (COPD) [8]. The
response of asthmatics to antibiotics also suggests the importance of
acute and chronic bacterial infections in the pathogenesis of disease [9].
Epidemiological research has consistently indicated that a rich
microbial environment in early life confers protection against the
development of asthma [1], suggesting the need to understand the
extent and nature of normal airway flora.
Apart from asthma, respiratory infections, excluding tuberculosis,
cause 6% of the global burden of disease and each year 4.2 million
people die of lower respiratory infections. Significantly, death in the
1918–1919, 1957 and 1968 influenza pandemics resulted most
commonly from secondary bacterial pneumonia caused by organisms
presumed to be previously present in the respiratory tract [10,11].
Chronic Obstructive Pulmonary Disease (COPD) shares many
features with asthma and is the fourth leading cause of death
worldwide. Infectious exacerbations of the disease are a frequent
cause of death, and chronic infection causes a progressive decline
of lung function.
Thus, despite strong evidence to implicate bacterial infections in
the course and pathogenesis of airway diseases, it is unfortunate
that a systematic study of organisms in the airways has been
lacking [12].
Only 1% of all bacteria can be cultured in the laboratory [13],
so culture is no longer the gold standard for the diagnosis of
infections. Culture-independent molecular methods have already
shown that the microbiota of humans is far greater in extent than
previously recognised [14,15,16]. Humans are recognised to have
evolved relationships with their symbiotic bacteria that are
essential for health. Ecological changes altering this symbiosis
can result in disease [17].
We therefore used molecular analysis of the polymorphic
bacterial 16S-rRNA gene to characterize the composition of
bacterial communities from the airways of adult subjects including
patients with asthma and COPD. We sought replication of
findings from these adults in an additional study of children
attending clinics for therapy-resistant asthma.
Results
Twenty-four adult subjects were studied, including 5 patients
with COPD, 11 patients with asthma and 8 control subjects with
no previous history of asthma or COPD and an FEV1$95%
PLoS ONE | www.plosone.org 1 January 2010 | Volume 5 | Issue 1 | e8578predicted (Table 1). Sterile dry cotton-headed swabs were used to
sample from the nose and the oropharynx (OP) of all subjects
(n=24), and bronchoscopy via the nasal route was used to obtain
duplicate cytology brushings within the left upper (LUL) in 23
subjects. All subjects were free of clinical infection at the time of
the study.
We sequenced clone libraries from the 16S rRNA PCR products
for 23, 24 and 21 samples from the nose, OP and LUL
respectively. Very weak amplification products were obtained
from three subjects with the lowest bacterial copy numbers and we
did not identify bacterial sequences from these libraries. After
excluding possible chimeras, 1,081 nasal, 1,100 OP and 1068 LUL
sequences were analysed further.
Distinct individual bacterial sequences (defined as operational
taxonomic units (OTUs)) were identified with the DOTUR
program. We estimated bacterial diversity, or the number of
different types of bacteria (OTUs) likely to be present, with Chao 1
statistics (using a cut-off of $97% sequence identity). This analysis
suggested the presence of 126 OTUs (95% Confidence Interval
[CI] 97.7–194.8) in the nasal samples, 229 (95%CI 142.9–434.1)
OTUs in the OP and 128 (95%CI 106.9–179.0) in the LUL
samples. These estimates indicated that we had identified 62% of
all OTUs in the nose and 68% of LUL OTUs, but only 35% of
the diversity in the OP. The values in the nose and LUL are
comparable with studies estimated to have identified 68.3% and
74.0% of OTUs in the human distal oesophagus [18] and forearm
superficial skin [19] respectively.
We combined nose, OP and LUL sequences together to
produce a global DOTUR analysis for the airways. This identified
190 OTUs of which 97 had more than a single sequence. Highly
abundant OTUs belonged to the genera Prevotella, Streptococcus,
Staphylococcus, Neisseria, Corynebacterium and to Haemophilus spp.
(Figure 1).
We used cladistic analysis to examine the distribution of phyla
and highly abundant genera at different airway levels (Figure 2
and Table 2). Nasal specimens were highly significantly char-
acterised by Actinobacteria (particularly Corynebacterium spp.)
(Pc,10
251) and Firmicutes (particularly Staphylococcus spp.)
(Pc,10
289). The most common bacteria in the OP were
Bacteroidetes (particularly Prevotella spp.) (Pc,10
225), and LUL
samples contained many more Haemophilus spp. than the other
sites (Pc,10
210).
A whole microbial community comparison showed the nasal
microbiota for all phenotypes to be clearly distinct from that of the
OP and LUL (Figure 3). The OP of healthy controls clustered with
OP samples of asthmatics and also with the controls’ LUL. The
LUL samples of patients with asthma and COPD clustered
together, along with the OP samples of patients with COPD.
These findings suggested that the microbiota of the healthy LUL
was similar to that of the healthy OP, but the LUL microbiota
differed from normal OP and LUL samples in the presence of
asthma and COPD. The analysis also suggested that the
microbiota in patients with COPD was altered in the OP as well
as the LUL, perhaps due to exposure to cigarette smoke both
regions.
We next studied the LUL samples in more detail for their
relationship to airway disease. Both series of 23 specimens from
the left upper lobe (LUL) were analysed in triplicate for bacterial
counts. The 16S rRNA copy number estimates indicated a range of
2–7,500 bacterial genomes per 40ng total DNA, or a mean of
2.2610
3 bacterial genomes per cm
2 surface sampled (range 62–
2.1610
5) based on an estimated brushed area of 2 cm
2 and one
copy of the 16S rRNA gene per genome. The repeat LUL
brushings gave highly reproducible counts (Spearman’s
rho=0.667, P,0.001). We excluded sample-specific PCR inhibi-
tion in subjects with low copy numbers by demonstrating
amplification of human DNA with equivalent intensity for all
samples.
Our mean estimate of 2,000 bacterial genomes per cm
2 surface
sampled from LUL brushings is comparable with estimates from
the upper two thirds of the small intestine [20]. The airway counts
are an order of magnitude below the 50,000 bacteria/cm
2
identified by 16S rRNA amplification of scrapings from normal
skin [16], although the maximum count of 20,000 we observed in
an asthmatic subject approximates this figure.
The genome copy number estimates were significantly lower in
smokers (Mann-Whitney U test Z=23.92, P,0.001). Similar
effects of smoking were observed in the duplicate samples
(Z=24.25, P,0.001) and in the nasal counts (Z=22.38,
P=0.016). The specimens from the RLL were in the same range
as for the LUL. No differences in the counts were found with
respect to age or sex. It may be relevant that cigarette smoking has
also been shown to influence bacterial growth in inflammatory
bowel disease (IBD) [21].
We performed cladistic association analysis to test for differences
in the frequency of particular phyla and genera between subject
groups (Figure 4a and Tables 3 and 5). We found members of the
phylum Proteobacteria to occur highly significantly more often in
the COPD (Pc,10
214) and asthma (Pc,10
213) groups compared to
controls (Table 3). In contrast, Bacteroidetes members were more
common in controls compared to diseased subjects (Pc,10
24
controls versus COPD; Pc,10
22 controls versus asthma). Members
of the genus Haemophilus were most strongly associated with the
presence of COPD (Pc,10
24) and asthma (Pc,10
27) (Table 1d).
In order to confirm if the same bacteria were relevant in health
and disease in a different set of patients we studied an additional
13 (5 female) asthmatic and 7 (3 female) control individuals
Table 1. Adult Patient Characteristics.
Asthma COPD Control
Number 11 5 8
Age (Mean+/2SD) 37.6+/218.2 57.0+/212.3 52.9+/211.1
Sex (% male) 72.7% 60.0% 37.5%
Current smoking (%) 9.1% 80.0% 25.0%
Pack Years (Mean+/2SD) 0.6+/21.4 41.0+/228.8 9.0+/217.4
FEV1 % Predicted (Mean+/2SD) 81.0+/221.6 51.2+/28.0 100.8+/28.6
% Reversibility (Mean+/2SD) 9.3+/211.6 9.8+/24.8 3.0+/24.7
DLCO (Mean+/SD) 91.2+/26.2 60.6+/213.1 88.0+/212.1
Medication (%)
ICS/LABA 100.0% 60.0% 0.0%
Tiotropium 9.1% 40.0% 0.0%
SABA 90.9% 60.0% 0.0%
Theophylline 18.2% 0.0% 0.0%
Oral steroids 9.1% 0.0% 0.0%
Singulair 27.3% 20.0% 0.0%
Severity (%)*
Severe 27.3%
Intermittent 27.3%
Mild/Moderate 45.5%
*based on the GINA criteria (http://www.ginasthma.com/).
doi:10.1371/journal.pone.0008578.t001
Airway Microbiota and Asthma
PLoS ONE | www.plosone.org 2 January 2010 | Volume 5 | Issue 1 | e8578Figure 1. Phylogenetic analysis of bacterial 16S rRNA DNA from the nose, oropharynx (OP) and left upper lobe (LUL) in adult
patients with COPD (C) or asthma (A) and healthy controls (N). The numbers of 16S rRNA gene phylotypes (OTUs) were calculated at 97%
sequence identity and single-sequence OTUs omitted. OTU designations are located at the termination of each branch and represent potential
organism names. Abundance of OTUs in each subject is indicated by different coloured squares (Yellow=1 single OTU, Orange=3–10%, Red=10–
20% and Black$20%).
doi:10.1371/journal.pone.0008578.g001
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the Royal Brompton Hospital (Table 4). The median age of the
asthmatic children was 11.862.8 years and that of the controls
was 11.365.7. None of the subjects had been taking antibiotics
prior to examination and all subjects were considered free of
infection. Broncho-alveolar lavage (BAL) was performed through a
fibre-optic bronchoscope, DNA extracted, and clone libraries
created and sequenced.
We obtained 1135 and 670 sequences respectively for the
asthmatic and control individuals. Based on 97% sequence
identity, this resulted in 97 (124.3 95%CI 108.3–163.2) and 68
(85.1 95%CI 73.7–119.4) OTUs for the asthma and control
individuals. Taking all subjects together, 131 OTUs were detected.
We found from the distribution of the phyla that Proteobacteria
were more frequent in asthmatic children compared to controls
(Pc,10
213), whereas Bacterioidetes were more common in the
controls than in asthmatics (Pc,10
216) (Figure 4b and Table 5). At
the level of genera, the asthmatic subjects were characterised by
excess of Haemophilus spp. (Pc,10
212) and Staphylococcus spp.
(Pc,10
22), whereas Prevotella spp. were more frequent in controls
(Pc,10
230).
Discussion
Our results challenge the traditional medical teaching that the
lower airways are sterile, and suggest that bronchial tree contains a
characteristic microbial flora that differs between health and
disease. The concept of sterility comes from an age with limited
experimental access to healthy airways and was based on 120 year
old culture techniques which are now recognised to detect a small
percentage of the bacteria present in complex samples [13].
Indeed, the major colonists in our control subjects were anaerobes
such as Prevotella spp., which can only be grown with difficulty in
culture. Microbiota are ubiquitous even in the most hostile
environments, and it would be extraordinary if the lower airway
able to maintain sterility in the presence of high volume airflow
through a damp open communication with the oropharynx.
Our results show strong similarities in the airway microbiota
between adult and paediatric asthmatics and controls (Figure 4),
despite sampling by two alternative methods (bronchial brushing
and BAL). Strikingly, members of the phylum Proteobacteria were
very strongly associated with airway disease in both groups. The
phylum contained the important potential pathogens Haemophilus,
Moraxella and Neisseria spp.
These associations, although robust, do not yet establish
causality between the presence of pathogens and airways disease.
Figure 2. Percentage distribution of common phyla and genera
at different airway levels (nose, OP and LUL), subdivided into
the seven most frequent genera (Croynebacterium, Prevotella,
Staphylococcus, Streptococcus, Veilonella, Haemophilus and Neis-
seria) found in the samples.
doi:10.1371/journal.pone.0008578.g002
Table 2. Cladistic association analysis: P-values for differences in phyla and genera between airway levels in adult subjects.
PHYLA LUL OP NOSE P* LUL vs. OP P LUL vs. nose P OP vs. Nose
Proteobacteria 302 230 207 2.08E203
Bacteroidetes 392 459 138 1.82E235 1.98E250
Firmicutes 297 347 447 1.44E207 7.57E203
Fusobacteria 38 18 34
Actinobacteria 34 45 253 4.23E244 6.30E239
GENERA
Actinobacteria/Corynebacterium 6 0 171 2.36E242 1.53E252
Other Actinobacteria 28 45 82 4.25E204
Bacteroidetes/Prevotella 330 423 121 2.36E226 1.93E247
Other Bacteroidetes 62 36 17 3.91E204
Firmicutes/Staphylococcus 9 0 277 4.38E274 1.46E290
Firmicutes/Streptococcus 110 106 65
Firmicutes/Veillonella 104 184 49 6.02E203 1.03E202 1.04E217
Other Firmicutes 74 57 56
Proteobacteria/Haemophilus 167 60 24 1.39E211 9.30E227 2.69E201
Proteobacteria/Neisseria 79 167 69 3.17E205 1.28E+03 7.39E208
Other Proteobacteria 56 3 114 5.59E211 1.51E202 1.15E228
The numbers of sequences are shown for each split level.
*Only significant P values are shown. The significance levels have been Bonferroni corrected for multiple comparisons.
doi:10.1371/journal.pone.0008578.t002
Airway Microbiota and Asthma
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of most cases of asthma. Our adult controls were healthy, but the
childhood controls had clinical indications for their bronchoscopy
including tracheomalacia, gastro-oesophageal reflux, and symp-
tomatic VSDs which might all cause airway mucosal abnormal-
ities. It is also not known to what extent past antibiotic usage in
response to symptoms of airway disease may have determined the
patterns of bacterial species we have detected. It is also possible
that the presence of pathogens in asthmatic airways is secondary to
mucosal abnormalities of as yet unknown cause.
Despite these cautions, it is striking that Haemophilus, Moraxella
and Neisseria spp. found by us in asthmatic airways have also been
shown to carry increased risk for asthma in early life when found
in neonatal throat swabs [6]. It should therefore be considered
possible that the presence of these pathogens may have some
influence on chronic airway inflammation, even when below the
threshold for routine culture. In addition, the presence of a low
copy-number yet dominant population of potential pathogens may
provide a substrate for full blown bacterial infection following
otherwise self-limiting viral infections [22] as well as following
pandemic influenza [10,11].
We are not aware of any trials of antibiotics in asthma other
than in the management of acute exacerbations [9], but It may be
relevant that protracted course of antibiotics are required for
successful therapy of the asthma overlap syndrome of chronic wet
cough [23]. The availability of effective vaccines against
Haemophilus influenzae might also open new therapeutic possibilities
for individuals whose airways disease is characterised by the
continued presence of this pathogen.
Our data suggest that Staphylococcus spp. are also present in
excess in the airways of children with difficult asthma, and it is
likely that wider exploration of children and adults with asthma
will identify a range of organisms associated with the disease,
including Mycoplasma spp. and Chlamydia spp. [24] and Streptococcus
spp. [6], and possibly defining subtypes of the syndrome.
Longitudinal studies are desirable to follow changes in the
microbiota during the acute exacerbations that are a prominent
feature of asthma and COPD.
Bacteroidetes (particularly Prevotella spp.) were more common in
control subjects than in diseased individuals. Prevotella are Gram-
negative anaerobes recognised to be part of the normal oral [25]
and vaginal flora and are the predominant anaerobic Gram-
negative bacilli isolated from respiratory tract infections and their
complications. They have been found in high numbers by 16S-
rRNA sequencing in the lungs of children with cystic fibrosis [26].
Our results suggest that Prevotella and Veillonella spp. are a
distinctive component of the normal flora of the lung as well as
other moist epithelia, and that their presence in normal airways
may not have been generally recognised because of their
requirement for anaerobic culture.
Figure 3. Bacterial community comparisons from the nose (N), oropharynx (OP) and left upper lobe (LUL) in adult patients with
COPD or asthma and healthy controls.
doi:10.1371/journal.pone.0008578.g003
Figure 4. Distribution of common phyla and genera in diseased and normal bronchi. a) Distribution of the phyla from sheathed
bronchoscopic brushings of the LUL for patients with asthma and COPD and normal subjects, subdivided into the seven most frequent genera
(Croynebacterium, Prevotella, Staphylococcus, Streptococcus, Veilonella, Haemophilus and Neisseria). b) Distribution of the phyla from bronhco-alveolar
lavage (BAL) in children with difficult asthma and controls.
doi:10.1371/journal.pone.0008578.g004
Airway Microbiota and Asthma
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subject groups.
PHYLA COPD Asthma Control P* COPD vs. Controls P Asthma vs. Controls
Proteobacteria 94 181 27 7.70E215 2.16E214
Bacterioidetes 62 179 151 3.38E205 7.17E203
Firmicutes 60 134 103
Fusobacteria 8 19 11
Actinobacteria 11 12 11
GENERA
Actinobacteria/Corynebacterium 4 0 2
Other Actinobacteria 7 12 9
Bacteroidetes/Prevotella 51 158 121 7.55E203
Other Bacteroidetes 11 21 30
Firmicutes/Staphylococcus 4 2 3
Firmicutes/Streptococcus 26 56 28
Firmicutes/Veillonella 18 45 41
Other Firmicutes 12 31 31
Proteobacteria/Haemophilus 46 108 13 2.06E205 1.17E208
Proteobacteria/Neisseria 24 44 11
Other Proteobacteria 24 29 3 9.22E204
Fusobacterium 8 19 11
The numbers of sequences are shown for each split level.
*Only significant P values are shown. The significance levels have been Bonferroni corrected for multiple comparisons.
doi:10.1371/journal.pone.0008578.t003
Table 4. Characteristics of childhood subjects.
ID Status Age Sex Ethnicity FEV1% Therapy
1 Asthma 9 f A 44 budes 1200/m5/form36/
2 Asthma 8 m Mix 79 Seretide 250 2p bd/pred 15 eod m5
3 Asthma 11 m C 98 symb 200 2P bd/theo300bd/Azithromycin 250 36wk/pred 6.25
4 Asthma 11 f C 83 salb prn/becotide 50 2PBD
5 Asthma 15 m C 86 Seretide 250 2PBD/
6 Asthma 9 m C 51 seretide 250 2p bd/m5/hydro 12.5 tds
7 Asthma 14 f C 65 Seretide 250 2PBD/pred 10 eod/
8 Asthma 11 m C 88 Servent 25 2pbd/flix 250 2pbd/PRED 15 EOD
9 Asthma 12 f A 73 Seretide 1252pbd/calcich 500bd/m5/pred 10od
10 Asthma 11 m Mix 63 symb 400 2 pbd/Slophyllin 125 bd/m5/pred 10 EOD
11 Asthma 15 m A N/A pulm 200 6P BD/M4/serevent 25 3PBD/omep 10 BD/domp 3 TDs
14 Asthma 14 f C 68 symb 400 2BB/M10/Slophyllin 250bd/domp 10tds/ome 20 od/sodium valp
15 Asthma 7 m C 92 symb 200 5 pbd/m8/domp10 tds/omep20bd/azathiop75od
13 Stridor on exercise 13 m C 84 Nil
52 laryngo and tracheomalacia 7 m C Normal Nil
78 VSD, bronched during cardiac catheter 1 m C Normal Nil
89 Recurrent haemoptysis, no resp symptoms 17 f C Normal Nil
98 Oesophageal reflux, productive cough 11 m C 78 Ventolin prn/domp/omepr/lansoprazole
300 Replacment of pacemaker 17 f C Normal Nil
348 Stridor, prev. surgery for vascular ring 12 f C Normal Nil
doi:10.1371/journal.pone.0008578.t004
Airway Microbiota and Asthma
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COPD compared to controls may also be relevant to disease. An
investigation of patients with IBD showed a 10-fold decrease in
total bacterial load and a diminished quantity of Bacteroidetes
compared with controls [21], consistent with findings in our
patients. It may be relevant that Prevotella spp. directly inhibit the
growth of other bacteria [27]. Commensal bacteria elicit tonic
signals in the gut epithelium that prevent activation of innate and
adaptive immune responses [28,29], and commensal bacteria
down-regulate immune responses to pathogens in the nasal
mucosa [30]. It is possible that similar mechanisms may
characterise healthy airways.
Materials and Methods
Approval for the adult study was given by the Connolly Hospital
Ethics Committee, and full informed consent was obtained from
each patient in writing. Approval for the study of the pediatric
patients was given Royal Brompton Hospital Ethics Committee,
and written informed consent from parents and age-appropriate
assent from children was obtained in each case.
Twenty-four adult subjects were studied, consisting of 5 patients
with COPD, 11 patients with asthma and 8 control subjects with
no previous history of asthma or COPD and an FEV1$95%
predicted (Table 1). Asthma severity was based on the GINA
criteria (http://www.ginasthma.com/). Smoking was defined as
current/recent (within the past two years), past (non-smoker for
more than two years) and never. Subjects were included in the
study regardless of smoking status. All patients were of European
descent and from Dublin. The patients received their usual
medical treatment in the 24 hours prior to this investigation. No
patients were taking antibiotics at the time of the study, and all
subjects were considered to be free of clinical infections.
Sterile dry cotton-headed swabs were used to sample from the
nose and the oropharynx (OP) of all subjects (n=24). Following
Propofol as a short-acting sedative agent and local Lidocaine
anaesthesia to the upper airway, bronchoscopy was performed
via the nasal route. Olympus Endotherapy disposable sheathed
cytology brushes (Model number BC-202D-5010) 5 mm diam-
eter and 10 mm length were used to brush within the left upper
(LUL) and right lower lobes (RLL). Duplicate brushings were
done for the LUL, attempting in each case to reach a more distal
area. One patient with severe asthma was unable to tolerate a
bronchoscopy. LUL brushings were therefore performed for 23
subjects. Fourteen of the subjects (five controls; three COPD
subjects and six asthma subjects) were sufficiently comfortable to
allow sampling of their RLLs. Approximately 2 cm
2 of bronchial
mucosa was covered by each brushing. Samples were either
processed immediately or stored in 2 ml tubes over night at
220uC prior to being processed.
We also studied thirteen paediatric patients with difficult asthma
and seven non-asthmatic controls (Table 2). Difficult asthma was
defined as symptoms requiring a rescue bronchodilator on at least
three days per week, despite treatment with at least 1600 mg/day
of inhaled budesonide (or equivalent), as well as regular long acting
b2 agonists (or a previous unsuccessful trial of long acting b2
agonists), and/or regular prednisolone [31]. None of the subjects
were taking antibiotics at the time of the study and all were
considered to be free of clinical infections. Fifteen children were
Caucasian, three were of African origin and one child was of
mixed origin (Table 4). The study had full ethical approval and all
subjects or their parents gave written informed consent.
Bronchoscopies in the paediatric subjects were performed as
previously described [31]. For the BAL, three aliquots of normal
saline (1 ml/kg, maximum 40 ml) were instilled in the right middle
lobe through the bronchoscope and the fluid retrieved by
mechanical suction. Between 0.4–8ml of BAL fluids were retrieved
and centrifuged and the pellet kept for subsequent DNA
extraction. In the case of three patients the pellets had been used
for a different study. We therefore again centrifuged the remaining
supernatants and processed these secondary pellets.
Samples were suspended in 450ml lysis solution (20 mg/ml
lysozyme; 20 mM Tris?HCl, pH 8.0; 2 mM EDTA) and incubat-
ed for 1h at 37uC with occasional vortexing. Subsequent DNA
extraction was performed as instructed by the manufacturer
(DNeasy, Qiagen). The purified DNA was resuspended in 40mlo f
analar water and the DNA concentration determined using a
Nanodrop ND-1000 spectrophotometer. For long term storage
samples were kept at 220uC. Working stocks containing 20 ng/ml
and 10 g/ml total DNA were prepared for samples from the LUL,
RLL and nose and these stocks were stored at 4uC.
To quantify the bacterial DNA content of each sample, 2mlo f
each prepared working stock was used as template in PCR
reactions containing 16S rRNA gene primers 63F-59 GCAGGCC-
TAACACATGCAAGTC-39 and 355R-59 CTGCTGCCTCCC-
GTAGGAGT-39 (final primer concentration 0.2 mM) with reac-
tion and cycling conditions as previously described [16]. A
standard curve was included, amplifying serial dilutions of known
quantities of Escherichia coli cells in the presence of 20 ng/ml human
DNA. For the left upper and right lower lobe samples the
functions used to calculate copy numbers were: Ct1=23.62x+
35.46 with R
2=0.994; Ct2=23.76x+36.30 with R
2=0.996 and
Ct3=23.73x+36.05 with R
2=0.996. For the nasal swabs, the
function used was: CtN=23.70x+35.91 with R
2=0.997. Copy
numbers were calculated with E. coli having 4,500,000 bp. Initial
experiments revealed no inhibition of amplification of E. coli in the
presence of human DNA and confirms findings described
Table 5. Cladistic association analysis: P-values for differences
in phyla and genera between broncho-alveolar lavage in
difficult childhood asthmatics and control subjects.
PHYLA Control Asthma P* Asthma vs. Controls
Proteobacteria 83 331 6.45E214
Bacterioidetes 282 239 1.13E217
Firmicutes 218 454
Fusobacteria 69 70
Actinobacteria 18 27
GENERA
Bacteroidetes/Prevotella 247 137 3.23E231
Other Bacteroidetes 35 102
Firmicutes/Staphylococcus 13 74 7.16E203
Firmicutes/Streptococcus 98 242
Firmicutes/Veillonella 69 90
Other Firmicutes 38 48
Proteobacteria/Haemophilus 17 154 1.44E213
Proteobacteria/Neisseria 53 77
Other Proteobacteria 13 100 1.01E206
Fusobacteria 69 70
The numbers of sequences are shown for each split level.
*Only significant P values are shown. The significance levels have been
Bonferroni corrected for multiple comparisons.
doi:10.1371/journal.pone.0008578.t005
Airway Microbiota and Asthma
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assessed using non-parametric tests in SPPS 16.0 for Windows.
For the sequencing analysis 16S rRNA genes were amplified
using the primers 339F-59-ACTCCTACGGGAGGCAGCAGT-
39 [15] and 907R-59-CCGTCAATTCMTTTGAGTTT-39 [32].
25ml PCR reactions were set up containing 2ml of template, 2.5ml
106buffer (Roche Applied Biosystems), and final concentrations
of 1.5 mM Mg, 6% DMSO, 0.5 mM primers, 0.8 mM total dNTP
(0.2 mM each) and 1U HotStart Polymerase (Roche Applied
Biosystems). Cycling conditions were one cycle of 95uC for 5 min,
then 32 cycles of 95uC for 30s, 55uC for 30s and 72uC for 60s
followed by a final extension of 72uC for 5 min.
Following amplification, the PCR products were separated on a
1% agarose gel, and bands corresponding to the target product
(,550bp) were excised. Cloning and sequencing of the PCR
products was possible for 21, 23, 24 and 20 primary LUL, nose, OP
and BAL samples respectively. A low concentration of amplification
product of 3 samples was attributed to low bacterial counts and
prevented reliable sequencing. PCR products were extracted from
the gel slices using the Qiaquick extraction kit according to the
manufacturer’s instructions (Qiagen) and resuspended in 40mlo f
analar water and stored at 4uC until further use.
Purified PCR products were cloned into the pGEM-T Easy
Vector (Promega) as per the manufacturer’s instructions. Between
48 and 72 colonies per ligation were picked at random. Plasmid
DNA was purified using the Qiagen Plasmid Miniprep Kit
according to the manufacturer’s instructions and sequenced using
the primer SP6. In instances when sequence from the SP6 primer
was of low quality, the alternate DNA strand was sequenced using
the T7 primer. DNA sequence chromatograms were uploaded to
the ribosomal database (http://rdp.cme.msu.edu/), vector sequenc-
es trimmed (using the LUCY program) and remaining sequences
quality control checked (using PHRED). Sequences of high quality
were downloaded, primer regions additionally trimmed and only
full length sequences ranging from 359 up to 906 (E. coli numbering
of the 16S rRNA gene) were included for further analysis.
Sequences were aligned with NAST [33] and ClustalW.
Alignments weremanually curated and results checkedfor chimeras
with Bellerophon Version 3 [34] on the Greengenes website
(http://greengenes.lbl.gov).Usingslightlyadjustedstandardsettings
(match length to core set=400 and window size of 200) putative
chimeras were identified and excluded from subsequent analyses.
Distance matrices calculating the pair wise distances of the high
quality sequences was created on the green genes website (http://
greengenes.lbl.gov/cgi-bin/nph-index.cgi), masking the hyper-var-
iable regions with the lane mask utility. OTUs were designated
using DOTUR (Distance based OTU and richness determination)
[35] by the furthest-neighbour algorithm. Chao 1 richness measures
of diversitywereestimated by thesameprogram.Forthecreation of
the phylogenetic tree, a cut off of 97% was set and each OTU was
then assigned an organism name based on the phylogenetic
placement using sequence match of the ribosomal database (20
best match sequences define taxanomic rank) and compared to
NCBI BLAST results for the percentage of sequence identity.
Cladistic association analysis was performed as a method for
association mapping [36]. The approach was based on the
observation that every edge in a phylogenetic tree defines a split of
the OTUs. P-values were calculated for association between the
groups and the split and for association between disease status of
individuals and the split. Two-tailed Fisher’s exact tests were
performed for each split, followed by the application of a
conservative Bonferroni correction [37] for multiple testing.
The UNIFRAC metric measures the distance between
communities as the percentage of branch length that leads to
descendants from only one of a pair of environments represented
in a single phylogenetic tree, i.e. the fraction of evolution that is
unique to one of the microbial communities. The metric thus
reflects differences between the lineages that are adapted to live
specifically in one environment or the others [38]. A phylogenetic
tree based on 16S rRNA DNA sequences was used as input to
measure the difference between bacterial communities in asthma,
COPD and controls by using UNIFRAC.
For Figure 1, the numbers of 16S rRNA gene phylotypes (OTUs)
were calculated at 99% sequence identity with the furthest
neighbour clustering in the program DOTUR. Using a single
sequence for each OTU, evolutionary distances were calculated
with the Jukes-Cantor (tree-Markov) model and phlyogenetic trees
determined by the Neighbour-Joining method, with 1000 trees
generated. Bootstrap confidence levels were shown at the tree
nodes for values for $50%. Designations of Streptococcus mitis and
Neisseria mucosa/sicca/flava were as described previously [39,40].
Bacterial community comparisons of PCR libraries were
determined with weighted UniFrac and the relationships are
displayed by the Unweighted Pair Group Method with Arithmetic
mean (UPGMA). Sequences of individuals with the same
phenotype and clinical site were pooled and sequence numbers
annotated. The tree with 100% identity was used as input. Only
individuals from whom all 3 sites resulted in bacterial sequences
are included (20 of 24 individuals; 2,871 of 3,259 sequences).
Sequences are stored as GenBank accession GQ360090-
GQ365143.
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